ATC Group: G04BE01 Alprostadil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G04BE01 in the ATC hierarchy

Level	Code	Title
`1`	G	Genito urinary system and sex hormones
`2`	G04	Urologicals
`3`	G04B	Other urologicals, incl. antispasmodics
`4`	G04BE	Drugs used in erectile dysfunction
`5`	G04BE01	Alprostadil

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
PAREN	Parenteral	20 ug
URETH	Urethral	0.25 mg

Active ingredients in G04BE01

Active Ingredient
Alprostadil
Alprostadil is chemically identical to prostaglandin E₁, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.

Related product monographs

Document	Type	Information Source
CAVERJECT Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
EDEX Powder for solution	MPI, US: SPL/Old	FDA, National Drug Code (US)
MUSE Urethral Stick	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PROSTIN E2 Concentrate for solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PROSTIN E2 Vaginal tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)